Result card

  • SOC12: How do patients and citizens perceive the information they receive or require about FIT and gFOBT?
Fecal Immunochemical Test (FIT ) versus guaiac-based fecal occult blood test (FOBT) for colorectal cancer screening
H0008
English
No adaptation help available for this domain

How do patients and citizens perceive the information they receive or require about FIT and gFOBT?

Authors: Pseudo275 Pseudo275, Pseudo108 Pseudo108

Internal reviewers: Pernilla Östlund, Claudia Santos

None of our included studies provided information on this topic.

None of our included studies provided information on this topic.

None of our included studies provided information on this topic.

None of our included studies provided information on this topic.

Pseudo275 P, Pseudo108 P Result Card SOC12 In: Pseudo275 P, Pseudo108 P Social aspects In: Jefferson T, Cerbo M, Vicari N [eds.]. Fecal Immunochemical Test (FIT ) versus guaiac-based fecal occult blood test (FOBT) for colorectal cancer screening [Core HTA], Agenas - Agenzia nazionale per i servizi sanitari regionali; 2014. [cited 17 August 2022]. Available from: http://corehta.info/ViewCover.aspx?id=206

References

Birkenfeld, S., et al. (2011). "Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test." J Med Screen 18(3): 135-141.

Cole, S. R., et al. (2003). "A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer." J Med Screen 10(3): 117-122.

Federici, A., et al. (2005). "The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial." J Med Screen 12(2): 83-88.

Hassan, C., et al. (2012). "Meta-analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test." Aliment Pharmacol Ther 36(10): 929-940.

Hawley, S. T., et al. (2008). "Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients." Med Care 46(9 Suppl 1): S10-16.

Hol, L., et al. (2010). "Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy." Eur J Cancer 46(11): 2059-2066.

Hol, L., et al. (2010). "Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy." Gut 59(1): 62-68.

Hughes, K., et al. (2005). "Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community." Aust N Z J Public Health 29(4): 358-364.

Levi, Z., et al. (2011). "A higher detection rate for colorectal cancer and advanced adenomatous polyp for  screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study." Int J Cancer 128(10): 2415-244.

Vernon, S.W. Participation in Colorectal Cancer Screening: a review , Journal of the National Cancer Institute , Vol. 89, No. 19, 1997.